Funded Tech Companies
Prexa Pharmaceuticals
Prexa Pharmaceuticals is a biopharmaceutical company, based in Boston. Venture investment and financing was provided by Shire Pharmaceuticals, Synthesis Capital and private investors.
Company Overview
Company Name
Prexa Pharmaceuticals
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
184 High St.
Boston, MA 02110
USA
Boston, MA 02110
USA
Phone
Website
Email Address
Company Background Information
Overview
Prexa, founded in 2006, is developing oral small molecule monoamine reuptake inhibitors that act most potently at the dopamine transporter. By safely enhancing dopamine activity and, to a lesser extent norepinephrine activity, Prexa intends to improve upon current treatments for ADHD, depression and Parkinson's disease.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
5/11/2011
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Charlie Cohen
Chief Medical Officer
Scott Reines
Chief Operating Officer
Evelyn Graham
Chief Technical Officer
Philip Huxley
Company Investors
- Shire Pharmaceuticals
- Synthesis Capital (Charles Cohen)
Browse more funded tech companies:
Share this article
About Our Venture Capital Database
This tech company profile is powered by VentureDeal.com, a market leader in private equity transaction data.
Additional Resources for Entrepreneurs